These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1367039)

  • 1. Purification and some properties of proliferation suppressing factor from human lung adenocarcinoma PC-8.
    Shinmoto H; Dosako S; Yamada K; Shirahata S; Murakami H
    Cytotechnology; 1990 Sep; 4(2):121-6. PubMed ID: 1367039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells.
    Brown TJ; Lioubin MN; Marquardt H
    J Immunol; 1987 Nov; 139(9):2977-83. PubMed ID: 3117884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification to apparent homogeneity of a factor stimulating the growth of multiple lineages of hemopoietic cells.
    Clark-Lewis I; Kent SB; Schrader JW
    J Biol Chem; 1984 Jun; 259(12):7488-94. PubMed ID: 6429132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
    Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
    J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a lymphokine produced by human T cells which inhibits collagen synthesis.
    Rosenbloom J; McArthur W; Malamud D; Jimenez S
    Cell Immunol; 1983 Oct; 81(1):192-8. PubMed ID: 6604586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant human T-cell line producing immunosuppressive factor(s).
    Lau CY; Budz-Tymkewycz S; Wang EY; Ishaque A
    Cell Immunol; 1984 Aug; 87(1):35-52. PubMed ID: 6234996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of murine liver-derived inhibitory protein.
    Wang SR; Huang MH; Chang KL; Tsai CY; Lin HY; Yu CL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):179-87. PubMed ID: 3149573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12).
    Harada N; Kikuchi Y; Tominaga A; Takaki S; Takatsu K
    J Immunol; 1985 Jun; 134(6):3944-51. PubMed ID: 3872907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia.
    Frank MB; Watson J; Mochizuki D; Gillis S
    J Immunol; 1981 Dec; 127(6):2361-5. PubMed ID: 6975318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.
    Welte K; Wang CY; Mertelsmann R; Venuta S; Feldman SP; Moore MA
    J Exp Med; 1982 Aug; 156(2):454-64. PubMed ID: 6980256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.
    Mier JW; Gallo RC
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6134-8. PubMed ID: 6969402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D; Stohl W; Mayer L
    J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of an inhibitor of lymphocyte proliferation present in spleen extracts].
    Casas JM; Vilardell A; Mas MJ; Cuchillo CM
    Rev Esp Oncol; 1983; 30(4):577-81. PubMed ID: 6599918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal requirements for growth and differentiation of activated murine B lymphocytes.
    Müller W; Kühn R; Goldmann W; Tesch H; Smith FI; Radbruch A; Rajewsky K
    J Immunol; 1985 Aug; 135(2):1213-9. PubMed ID: 3874233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-replacing factor in specific antibody responses to influenza virus by human blood B cells.
    Callard RE; Booth RJ; Brown MH; McCaughan GW
    Eur J Immunol; 1985 Jan; 15(1):52-9. PubMed ID: 2578400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-cell growth factor: purification biochemical characterization, and interaction with a cellular receptor.
    Robb RJ
    Immunobiology; 1982 Mar; 161(1-2):21-50. PubMed ID: 7047366
    [No Abstract]   [Full Text] [Related]  

  • 18. Distinction of B cell maturation factors from lymphokines affecting B cell growth and viability.
    Sherris DI; Sidman CL
    J Immunol; 1986 Feb; 136(3):994-8. PubMed ID: 3079808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacrimal gland-derived lymphocyte proliferation potentiating factor.
    Liu SH; Zhou DH; Franklin RM
    Invest Ophthalmol Vis Sci; 1993 Mar; 34(3):650-7. PubMed ID: 8449683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells.
    Godard A; Gascan H; Naulet J; Peyrat MA; Jacques Y; Soulillou JP; Moreau JF
    Blood; 1988 Jun; 71(6):1618-23. PubMed ID: 3130906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.